rethinkPeptides Search
Menu
Research citation

Central administration of galanin-like peptide (GALP) causes short-term orexigenic effects in broilers: Mediatory role of NPY1 and D1 receptors.

Preclinical Study (Animal Model)Low (Animal Study) evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

What the researchers found

Galanin-like peptide (GALP) increased food intake in broiler chicks through NPY1 and D1 dopamine receptors. Blocking NPY1 suppressed the effect; blocking D1 enhanced it.

Why it matters

Understanding how appetite-regulating peptides interact with dopamine and NPY systems in poultry could improve feed efficiency and reveal conserved mechanisms relevant to human appetite research.

The numbers in context

GALP doses: 0.5, 1, 2 mcg; 1 and 2 mcg increased food intake (p<0.05); NPY1 antagonist (BIBO-3304) blocked effect; D1 antagonist (SCH39166) enhanced effect; NPY2, NPY5, D2 antagonists had no effect

How the study worked

Central (intracerebroventricular) peptide and antagonist administration in broiler chicks. Cumulative food intake measured over 2 hours. Behavioral observations for 30 minutes. Six experiments testing different receptor antagonist combinations.

Who was studied

Broiler chicks receiving central administration of GALP and receptor antagonists

What this study cannot tell us

Poultry model; brain peptide pathways may differ from mammals. Acute single-injection protocol. Central administration bypasses normal delivery. Small sample sizes typical of poultry neuroscience.

Read the original research

Central administration of galanin-like peptide (GALP) causes short-term orexigenic effects in broilers: Mediatory role of NPY1 and D1 receptors.

Neuroscience letters, 844, 138042

Citation

Sanadgol, Elham; Zendehdel, Morteza; Vazir, Bita; Rassouli, Ali; Haghbinnazarpak, Hadi. (2025). Central administration of galanin-like peptide (GALP) causes short-term orexigenic effects in broilers: Mediatory role of NPY1 and D1 receptors.. Neuroscience letters, 844, 138042. https://doi.org/10.1016/j.neulet.2024.138042